TY - JOUR
T1 - Multifunctional temozolomide-loaded lipid superparamagnetic nanovectors
T2 - Dual targeting and disintegration of glioblastoma spheroids by synergic chemotherapy and hyperthermia treatment
AU - Marino, Attilio
AU - Camponovo, Alice
AU - Degl'Innocenti, Andrea
AU - Bartolucci, Martina
AU - Tapeinos, Christos
AU - Martinelli, Chiara
AU - De Pasquale, Daniele
AU - Santoro, Francesca
AU - Mollo, Valentina
AU - Arai, Satoshi
AU - Suzuki, Madoka
AU - Harada, Yoshie
AU - Petretto, Andrea
AU - Ciofani, Gianni
N1 - Funding Information:
This work has received funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program (grant agreement No. 709613, SlaMM; to GC). Moreover, the Japan Science and Technology Agency (grant number JPMJPR15F5; to MS), the Human Frontier Science Program (grant number RGP0047/2018; to MS), and the JSPS (grant number 15H05931; to YH) are acknowledged. We finally gratefully thank Professor Young-Tae Chang (Pohang University of Science and Technology, Korea) for kindly providing the fluorescent ER-thermo yellow thermometer.
Funding Information:
This work has received funding from the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation program (grant agreement No. 709613, SlaMM; to GC).
Funding Information:
Moreover, the Japan Science and Technology Agency (grant number JPMJPR15F5; to MS), the Human Frontier Science Program (grant number RGP0047/2018; to MS), and the JSPS (grant number 15H05931; to YH) are acknowledged.
Publisher Copyright:
© 2019 The Royal Society of Chemistry.
PY - 2019/11/28
Y1 - 2019/11/28
N2 - Aiming at finding new solutions for fighting glioblastoma multiforme, one of the most aggressive and lethal human cancer, here an in vitro validation of multifunctional nanovectors for drug delivery and hyperthermia therapy is proposed. Hybrid magnetic lipid nanoparticles have been fully characterized and tested on a multi-cellular complex model resembling the tumor microenvironment. Investigations of cancer therapy based on a physical approach (namely hyperthermia) and on a pharmaceutical approach (by exploiting the chemotherapeutic drug temozolomide) have been extensively carried out, by evaluating its antiproliferative and pro-apoptotic effects on 3D models of glioblastoma multiforme. A systematic study of transcytosis and endocytosis mechanisms has been moreover performed with multiple complimentary investigations, besides a detailed description of local temperature increments following hyperthermia application. Finally, an in-depth proteomic analysis corroborated the obtained findings, which can be summarized in the preparation of a versatile, multifunctional, and effective nanoplatform able to overcome the blood-brain barrier and to induce powerful anti-cancer effects on in vitro complex models.
AB - Aiming at finding new solutions for fighting glioblastoma multiforme, one of the most aggressive and lethal human cancer, here an in vitro validation of multifunctional nanovectors for drug delivery and hyperthermia therapy is proposed. Hybrid magnetic lipid nanoparticles have been fully characterized and tested on a multi-cellular complex model resembling the tumor microenvironment. Investigations of cancer therapy based on a physical approach (namely hyperthermia) and on a pharmaceutical approach (by exploiting the chemotherapeutic drug temozolomide) have been extensively carried out, by evaluating its antiproliferative and pro-apoptotic effects on 3D models of glioblastoma multiforme. A systematic study of transcytosis and endocytosis mechanisms has been moreover performed with multiple complimentary investigations, besides a detailed description of local temperature increments following hyperthermia application. Finally, an in-depth proteomic analysis corroborated the obtained findings, which can be summarized in the preparation of a versatile, multifunctional, and effective nanoplatform able to overcome the blood-brain barrier and to induce powerful anti-cancer effects on in vitro complex models.
UR - http://www.scopus.com/inward/record.url?scp=85074965065&partnerID=8YFLogxK
U2 - 10.1039/c9nr07976a
DO - 10.1039/c9nr07976a
M3 - Article
C2 - 31663592
AN - SCOPUS:85074965065
SN - 2040-3364
VL - 11
SP - 21227
EP - 21248
JO - Nanoscale
JF - Nanoscale
IS - 44
ER -